These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19419141)

  • 1. Discovery of 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744) as a novel positive allosteric modulator of the alpha7 nicotinic acetylcholine receptor.
    Faghih R; Gopalakrishnan SM; Gronlien JH; Malysz J; Briggs CA; Wetterstrand C; Ween H; Curtis MP; Sarris KA; Gfesser GA; El-Kouhen R; Robb HM; Radek RJ; Marsh KC; Bunnelle WH; Gopalakrishnan M
    J Med Chem; 2009 May; 52(10):3377-84. PubMed ID: 19419141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro pharmacological characterization of a novel allosteric modulator of alpha 7 neuronal acetylcholine receptor, 4-(5-(4-chlorophenyl)-2-methyl-3-propionyl-1H-pyrrol-1-yl)benzenesulfonamide (A-867744), exhibiting unique pharmacological profile.
    Malysz J; Grønlien JH; Anderson DJ; Håkerud M; Thorin-Hagene K; Ween H; Wetterstrand C; Briggs CA; Faghih R; Bunnelle WH; Gopalakrishnan M
    J Pharmacol Exp Ther; 2009 Jul; 330(1):257-67. PubMed ID: 19389923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro pharmacological characterization of a novel selective alpha7 neuronal nicotinic acetylcholine receptor agonist ABT-107.
    Malysz J; Anderson DJ; Grønlien JH; Ji J; Bunnelle WH; Håkerud M; Thorin-Hagene K; Ween H; Helfrich R; Hu M; Gubbins E; Gopalakrishnan S; Puttfarcken PS; Briggs CA; Li J; Meyer MD; Dyhring T; Ahring PK; Nielsen EØ; Peters D; Timmermann DB; Gopalakrishnan M
    J Pharmacol Exp Ther; 2010 Sep; 334(3):863-74. PubMed ID: 20504915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An allosteric modulator of the alpha7 nicotinic acetylcholine receptor possessing cognition-enhancing properties in vivo.
    Timmermann DB; Grønlien JH; Kohlhaas KL; Nielsen EØ; Dam E; Jørgensen TD; Ahring PK; Peters D; Holst D; Christensen JK; Malysz J; Briggs CA; Gopalakrishnan M; Olsen GM
    J Pharmacol Exp Ther; 2007 Oct; 323(1):294-307. PubMed ID: 17625074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nootropic alpha7 nicotinic receptor allosteric modulator derived from GABAA receptor modulators.
    Ng HJ; Whittemore ER; Tran MB; Hogenkamp DJ; Broide RS; Johnstone TB; Zheng L; Stevens KE; Gee KW
    Proc Natl Acad Sci U S A; 2007 May; 104(19):8059-64. PubMed ID: 17470817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor: ligand interactions with distinct binding sites and evidence for a prominent role of the M2-M3 segment.
    Bertrand D; Bertrand S; Cassar S; Gubbins E; Li J; Gopalakrishnan M
    Mol Pharmacol; 2008 Nov; 74(5):1407-16. PubMed ID: 18678621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric modulation of nicotinic acetylcholine receptors.
    Bertrand D; Gopalakrishnan M
    Biochem Pharmacol; 2007 Oct; 74(8):1155-63. PubMed ID: 17707779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive allosteric modulation of alpha7 neuronal nicotinic acetylcholine receptors: lack of cytotoxicity in PC12 cells and rat primary cortical neurons.
    Hu M; Gopalakrishnan M; Li J
    Br J Pharmacol; 2009 Dec; 158(8):1857-64. PubMed ID: 20050184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of Novel, Potent, Brain-Permeable, and Orally Efficacious Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptor [4-(5-(4-Chlorophenyl)-4-methyl-2-propionylthiophen-3-yl)benzenesulfonamide]: Structure-Activity Relationship and Preclinical Characterization.
    Sinha N; Karche NP; Verma MK; Walunj SS; Nigade PB; Jana G; Kurhade SP; Hajare AK; Tilekar AR; Jadhav GR; Thube BR; Shaikh JS; Balgude S; Singh LB; Mahimane V; Adurkar SK; Hatnapure G; Raje F; Bhosale Y; Bhanage D; Sachchidanand S; Dixit R; Gupta R; Bokare AM; Dandekar M; Bharne A; Chatterjee M; Desai S; Koul S; Modi D; Mehta M; Patil V; Singh M; Gundu J; Goel RN; Shah C; Sharma S; Bakhle D; Kamboj RK; Palle VP
    J Med Chem; 2020 Feb; 63(3):944-960. PubMed ID: 31755711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Old and new pharmacology: positive allosteric modulation of the alpha7 nicotinic acetylcholine receptor by the 5-hydroxytryptamine(2B/C) receptor antagonist SB-206553 (3,5-dihydro-5-methyl-N-3-pyridinylbenzo[1,2-b:4,5-b']di pyrrole-1(2H)-carboxamide).
    Dunlop J; Lock T; Jow B; Sitzia F; Grauer S; Jow F; Kramer A; Bowlby MR; Randall A; Kowal D; Gilbert A; Comery TA; Larocque J; Soloveva V; Brown J; Roncarati R
    J Pharmacol Exp Ther; 2009 Mar; 328(3):766-76. PubMed ID: 19050173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators using the parallel oocyte electrophysiology test station.
    Malysz J; Grønlien JH; Timmermann DB; Håkerud M; Thorin-Hagene K; Ween H; Trumbull JD; Xiong Y; Briggs CA; Ahring PK; Dyhring T; Gopalakrishnan M
    Assay Drug Dev Technol; 2009 Aug; 7(4):374-90. PubMed ID: 19689206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro screening strategies for nicotinic receptor ligands.
    Dunlop J; Roncarati R; Jow B; Bothmann H; Lock T; Kowal D; Bowlby M; Terstappen GC
    Biochem Pharmacol; 2007 Oct; 74(8):1172-81. PubMed ID: 17706607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative allosteric modulation of nicotinic acetylcholine receptors blocks nicotine self-administration in rats.
    Yoshimura RF; Hogenkamp DJ; Li WY; Tran MB; Belluzzi JD; Whittemore ER; Leslie FM; Gee KW
    J Pharmacol Exp Ther; 2007 Dec; 323(3):907-15. PubMed ID: 17873105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and structure-activity relationship of quinuclidine benzamides as agonists of alpha7 nicotinic acetylcholine receptors.
    Bodnar AL; Cortes-Burgos LA; Cook KK; Dinh DM; Groppi VE; Hajos M; Higdon NR; Hoffmann WE; Hurst RS; Myers JK; Rogers BN; Wall TM; Wolfe ML; Wong E
    J Med Chem; 2005 Feb; 48(4):905-8. PubMed ID: 15715459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of the alpha7 nicotinic acetylcholine receptor agonists. (R)-3'-(5-Chlorothiophen-2-yl)spiro-1-azabicyclo[2.2.2]octane-3,5'-[1',3']oxazolidin-2'-one as a novel, potent, selective, and orally bioavailable ligand.
    Tatsumi R; Fujio M; Satoh H; Katayama J; Takanashi S; Hashimoto K; Tanaka H
    J Med Chem; 2005 Apr; 48(7):2678-86. PubMed ID: 15801858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenia and the alpha7 nicotinic acetylcholine receptor.
    Martin LF; Freedman R
    Int Rev Neurobiol; 2007; 78():225-46. PubMed ID: 17349863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric modulation of alpha 7 nicotinic receptors selectively depolarizes hippocampal interneurons, enhancing spontaneous GABAergic transmission.
    Arnaiz-Cot JJ; González JC; Sobrado M; Baldelli P; Carbone E; Gandía L; García AG; Hernández-Guijo JM
    Eur J Neurosci; 2008 Mar; 27(5):1097-110. PubMed ID: 18312591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and optimization of Lu AF58801, a novel, selective and brain penetrant positive allosteric modulator of alpha-7 nicotinic acetylcholine receptors: attenuation of subchronic phencyclidine (PCP)-induced cognitive deficits in rats following oral administration.
    Eskildsen J; Redrobe JP; Sams AG; Dekermendjian K; Laursen M; Boll JB; Papke RL; Bundgaard C; Frederiksen K; Bastlund JF
    Bioorg Med Chem Lett; 2014 Jan; 24(1):288-93. PubMed ID: 24291041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of nicotinic acetylcholine receptor channel function by acetylcholinesterase inhibitors in rat hippocampal CA1 interneurons.
    Fayuk D; Yakel JL
    Mol Pharmacol; 2004 Sep; 66(3):658-66. PubMed ID: 15322258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain.
    Feuerbach D; Lingenhoehl K; Olpe HR; Vassout A; Gentsch C; Chaperon F; Nozulak J; Enz A; Bilbe G; McAllister K; Hoyer D
    Neuropharmacology; 2009 Jan; 56(1):254-63. PubMed ID: 18793655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.